Coloplast Affirms FY26 Organic Revenue Growth Outlook
12 maj, 10:12
12 maj, 10:12
04:12 AM EDT, 05/12/2026 (MT Newswires) -- Coloplast (COLO-B.CO) confirmed its financial guidance for its organic revenue growth for 2026.
The Danish medical device company expects organic revenue to increase 5% to 6% in the full year, according to a Tuesday release.
The reported revenue growth in Danish kroner is expected to be around 3% due to the negative currency impact.
12 maj, 10:12
04:12 AM EDT, 05/12/2026 (MT Newswires) -- Coloplast (COLO-B.CO) confirmed its financial guidance for its organic revenue growth for 2026.
The Danish medical device company expects organic revenue to increase 5% to 6% in the full year, according to a Tuesday release.
The reported revenue growth in Danish kroner is expected to be around 3% due to the negative currency impact.
Kinnevik
Kinnevik
1 DAG %
Senast
OMX Stockholm 30
−0,96%
(vid stängning)
Octave Intelligence
Idag, 15:10
Octave: Hårt polerat case
OMX Stockholm 30
1 DAG %
Senast
3 162,19